COMMUNIQUÉS West-GlobeNewswire

Fennec Announces Pricing of Public Offering
08/12/2017
RESEARCH TRIANGLE PARK, N.C., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC ) (TSX: FRX ), a biotechnology company focused on the development of PEDMARK TM (a unique formulation of sodium [...]
Marrone Bio Innovations Announces the Availability of Amplitude™ Biofungicide for White Mold Control in the 2018 Growing Season
08/12/2017
DAVIS, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and [...]
TG Therapeutics, Inc. Recaps Data Presentations at the Upcoming 59th American Society of Hematology Annual Meeting
08/12/2017
NEW YORK, Dec. 08, 2017 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX ), today recapped the schedule of data presentations for the Company’s lead compounds, TGR-1202, (umbralisib), the Company's once-daily [...]
Allscripts hits record-breaking 1 billion API data shares in a single year
08/12/2017
CHICAGO, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) continues to lead the industry in innovation, interoperability, data sharing, and connectivity as it hits an industry leading milestone of one [...]
Aeterna Zentaris Announces Departure of Interim Chief Financial Officer
08/12/2017
CHARLESTON, S.C., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) (the “Company”) announced today the departure of the Company’s Interim Chief Financial Officer, Jeffrey Whitnell, [...]
Soleno Therapeutics Announces Joint Venture Agreement for Development and Commercialization of CoSense Monitoring Technology
08/12/2017
REDWOOD CITY, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO ), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today [...]
Wellness Center USA, Inc. Bolsters Corporate Management and Board Membership
08/12/2017
HOFFMAN ESTATES, IL , Dec. 08, 2017 (GLOBE NEWSWIRE) -- Wellness Center USA, Inc. (OTCQB: WCUI ), today announced the appointments of Mr. Paul D. Jones as the Company’s President, Thomas E. Scott, CPA, as the Company’s [...]
Aphios Pharma Raising Equity Capital to Develop FDA-Approved, Cannabis-Based Drug for Opioid Addiction
08/12/2017
WOBURN, Mass., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Aphios ® Pharma today announced plans to raise equity capital from investors to develop an FDA-approved, cannabis-based drug for treating opioid addiction, a highly unmet [...]
Stemline Therapeutics Announces Four SL-401 Presentations at Upcoming ASH Meeting
08/12/2017
NEW YORK, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today that SL- [...]
SteadyMed Announces FDA Agreed Pathway to Trevyent NDA Resubmission
08/12/2017
SAN RAMON, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq: STDY ), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with [...]
Nicotinamide Riboside Shown to Improve Mitochondrial Energy Production and Memory in Alzheimer’s Disease Research
08/12/2017
IRVINE, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), a science-based, fully integrated nutraceutical company devoted to extending human healthspan, announced today that in research [...]
OraSure Technologies Announces 2018 Annual Meeting Date
08/12/2017
BETHLEHEM, Pa., Dec. 08, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ) today announced that its 2018 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT (7:00 a.m. PDT) on [...]
Veritas Hires Medical Director to Advise Physicians & Regulators on the Application of Cannevert’s Experimental Results with Cannabis to Clinical Practice & Public Policy
08/12/2017
VANCOUVER, British Columbia, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) is pleased to announce the hiring of Dr. M. Scott Alexander as [...]
ERYTECH Reports Top-line Results of Phase 2b Study of Eryaspase for the Treatment of AML
08/12/2017
ERYTECH Reports Top-line Results of Phase 2b Study of Eryaspase for the Treatment of AML Conference call and webcast to take place Monday, December 11th at 10:00 a.m. EST LYON, France - December 8, 2017 - ERYTECH Pharma [...]
Photocure ASA: Landmark Blue Light Cystoscopy with Cysview® study is published in the Journal of Urology
08/12/2017
Oslo, Norway, December 8, 2017: Photocure ASA (Photocure, PHO: OSE), today announced that the official Journal of the American Urologic Association (AUA), the Journal of Urology, published the BLFCC Efficacy results [...]
Patient Enrolment in Phase II CIRCLE Study Evaluating THR-409 (ocriplasmin) for Non-Proliferative Diabetic Retinopathy (NPDR) Discontinued due to Slow Recruitment Rate
08/12/2017
Resources redirected to progress new drug candidates to clinic in H1 2018 Press release Leuven, Belgium, 8 December 2017 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel medicines [...]
Sandoz announces new Phase I data showing proposed biosimilar pegfilgrastim matches reference medicine
08/12/2017
Phase I study demonstrates matching pharmacokinetic (PK), pharmacodynamic (PD), safety and immunogenicity profiles of Sandoz biosimilar pegfilgrastim and reference medicine Pegfilgrastim is a long-acting version of the [...]
Aquinox Statement on FDA Advisory Committee Meeting to Discuss Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
08/12/2017
- Bone, Reproductive, and Urologic Drugs Advisory Committee Votes Unanimously in Favor of Unified IC/BPS Population for Clinical Trials - SILVER SPRING, Md., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , [...]
Denali Therapeutics Announces Pricing of Initial Public Offering
08/12/2017
SOUTH SAN FRANCISCO, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI ) today announced the pricing of its initial public offering of 13,888,888 shares of its common stock at a price to [...]

Pages